A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis - Related Studies

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

This study has been completed.

Study NCT00006280. Last updated on June 23, 2005. Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cystic Fibrosis

2	Additional conditions recognized in this trial
		Fibrosis

3	More general conditions related to this trial
		Digestive System Diseases
		Genetic Diseases, Inborn
		Infant, Newborn, Diseases
		Lung Diseases
		Pancreatic Diseases
		Pathologic Processes
		Respiratory Tract Diseases

4	Interventions listed in this trial
		Tobramycin for Inhalation

5	Additional drug interventions recognized in this trial
		Tobramycin

6	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
		National Center for Research Resources (NCRR)